Loading...
LFCH.Y logo

China Life Insurance Company LimitedOTCPK:LFCH.Y Rapport sur les actions

Capitalisation boursière US$101.6b
Prix de l'action
n/a
1Y-30.1%
7D3.0%
1D3.8%
Valeur du portefeuille
​
Voir

China Life Insurance Company Limited

OTCPK:LFCH.Y Rapport sur les actions

Capitalisation boursière : US$101.6b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

China Life Insurance (LFCH.Y) Aperçu de l'action

Operates as a life insurance company in the People’s Republic of China. Plus de détails

LFCH.Y analyse fondamentale
Score flocon de neige
Évaluation5/6
Croissance future2/6
Performances passées2/6
Santé financière4/6
Dividendes5/6

Récompenses

Se négocie à 70.4% en dessous de notre estimation de sa juste valeur

Les bénéfices devraient augmenter 18.52% par an

Se négocie à un bon prix par rapport à ses pairs et au secteur

Analyse des risques

Les marges bénéficiaires (4.4%) sont inférieures à celles de l'année dernière (6.4%)

Historique instable des dividendes


LFCH.Y Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW487,122 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
487,122 investors already sharing narratives
View all narratives

China Life Insurance Company Limited Concurrents

Historique des prix et performances

Résumé des hausses, des baisses et des variations du cours de l'action pour la période du 1er janvier au 31 décembre 2009 China Life Insurance
Historique des cours de bourse
Prix actuel de l'actionHK$6.21
Plus haut sur 52 semainesHK$9.69
Plus bas sur 52 semainesHK$5.40
Bêta0.69
Variation sur 1 mois0.73%
Variation sur 3 mois-16.08%
Variation sur 1 an-30.15%
Variation sur 3 ans-52.60%
Variation sur 5 ans-63.96%
Évolution depuis l'introduction en bourse109.44%

Nouvelles et mises à jour récentes

Recent updates

Seeking Alpha • Aug 25

China Life Insurance reports 1H results

China Life Insurance press release (NYSE:LFC): 1H Net profit of RMB25.42B Revenue of RMB516.67B. Gross written premiums were RMB439.97B
Seeking Alpha • Aug 02

China Life Insurance President resigns, new President appointed

China Life Insurance (NYSE:LFC) announced that due to the adjustment of work arrangements, Mr. Su Hengxuan tendered his resignation as the President, an Executive Director and a member of the Strategy and Assets and Liabilities Management Committee of the company on Aug. 1, 2022. He had no disagreement with the board and there are no other matters relating to his resignation. Mr. Zhao Peng was appointed as the President of the company and nominated as an Executive Director of the board. Most recently, he served as VP, Agricultural Development Bank of China.
Seeking Alpha • Jul 15

China Life Insurance: Fundamentals Remain Intact

Fundamentals are still strong for this large life insurance company. China should offer growth for this industry, as the demand is there. Valuation is still attractive at today's price level. Investment thesis My last article on China Life Insurance Company Limited (LFC) back in March this year came with a Buy call on the company, as I concluded that it offered good value at that time. If you had bought the shares at that time, you could take some comfort in knowing that your book value would now be down by just roughly 3% against a backdrop of the S&P500 going down more than 16% China Life Insurance versus SPY (SA) Alpha is alpha – even if the return is negative, which brings me to my last article on Blackrock’s China A-share ETF (CNYA), where I pointed out that it looks to me that China at this moment offers better prospects of improved return as opposed to Europe and to a lesser extent also the U.S. The reason for this you will find in that article. Back to China Life, perhaps as an alternative to buying the ETF CNYA one could use China Life as a good proxy for exposure to China. Recent development We will only get the interim financial report for 2022 around the 25th of August this year. However, we do have an indication of how some of the top lines for the first half of this year have fared, as they have reported accumulated premium income from 1st January to 30st June of 2022 and it came in at RMB 439.7 billion. This is slightly lower than the first half of 2020 when they recorded RMB 442.3 billion in premium. It should be expected, as the lockdown in the first half of this year may have put a damper on growth in premiums. More and more of their customers do now sign on for insurance online, but there are still those that prefer to sit down with a person in a branch office. Something which was hard to do due to Covid-19 restrictions. In the last few weeks, the central government has reduced quarantine times and eased some Covid-19 prevention measures. However, we do see that in different parts of China there has been a rise in new cases. But things are hopefully changing for the better. Consultancy firm Oliver Wyman predicted in a report published in March this year that China’s life insurance premiums are expected to surpass the U.S. market and become the world’s largest market by 2030. Annuity and endowment products presently only cover about RMB 30 trillion, which is much lower than the population’s expected pension needs. This highlights the gap and opportunities for insurers like LFC. A side note on investor activism LFC is among the largest shareholders in two of the largest position in my portfolio. These are HSBC (HSBC) and Hui Xian REIT, which is listed in Hong Kong under 8700.HK and controlled by CK Asset Holding (CHKGF). With regards to Hui Xian REIT, I have recently written to the board of directors and explained to them that it is not in the shareholder's interest that the company issues new units to settle distribution and management fees now that they are trading at a discount to NAV of 75%. Over the last ten years, they have added more than one billion new units, diluting the share count with 22.3% additional units without adding any productive assets to the balance sheet. As a matter of fact, they should be buying back and canceling shares at this point in time. So far, I have not received any response from Hui Xian REIT. My next step will be to reach out to LFC, and other shareholders, with the aim of getting their support for my request to Hui Xian REIT of terminating the issuance of new units at this moment. Hopefully, they can see the merits of my request and will want to take action. Risk to the thesis Under the leadership of Xi Jinping, China wants to make sure that the difference between the rich and poor, which is huge in China, should be addressed. That is not a bad thing.
Seeking Alpha • Mar 29

China Life Insurance: Continues To Offer Good Value

China Life's valuation is very attractive based on financial fundamentals. Share price has gone further down since my last buy call. We look at 2021 fiscal year results and revisit the investment thesis.
Seeking Alpha • Dec 16

China Life Insurance: One Year Cash Flow Greater Than Its Value

Fundamentals of China Life Insurance are good. Valuation is very attractive. Risks lie in the unknown things like liabilities in the accounts and further limitations to profit from future regulations.
Seeking Alpha • Aug 06

China Life Insurance Company Limited: Risky, But Upside Potentially Significant

The life insurance industry in China could see strong growth in the decade ahead. This stock could see significant exposure to risk in a low interest rate environment. However, should earnings growth remain solid, then I see potentially strong upside.

Rendement pour les actionnaires

LFCH.YUS InsuranceUS Marché
7D3.0%-0.7%0.09%
1Y-30.1%6.7%19.0%

Rendement vs Industrie: LFCH.Y a sous-performé le secteur US Insurance qui a rapporté 6.7 % au cours de l'année écoulée.

Rendement vs marché: LFCH.Y a sous-performé le marché US qui a rapporté 19 % au cours de l'année écoulée.

Volatilité des prix

Is LFCH.Y's price volatile compared to industry and market?
LFCH.Y volatility
LFCH.Y Average Weekly Movement4.9%
Insurance Industry Average Movement4.7%
Market Average Movement7.2%
10% most volatile stocks in US Market16.3%
10% least volatile stocks in US Market3.1%

Cours de l'action stable: LFCH.Y n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.

Volatilité au fil du temps: La volatilité hebdomadaire de LFCH.Y ( 5% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
1949102,195n/awww.e-chinalife.com

China Life Insurance Company Limited Résumé des fondamentaux

Comment les bénéfices et les revenus de China Life Insurance se comparent-ils à sa capitalisation boursière ?
LFCH.Y statistiques fondamentales
Capitalisation boursièreUS$101.59b
Bénéfices(TTM)US$4.72b
Recettes(TTM)US$108.50b
7.8x
Ratio P/E
0.3x
Ratio P/S

Le site LFCH.Y est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
LFCH.Y compte de résultat (TTM)
RecettesCN¥771.15b
Coût des recettesCN¥682.19b
Marge bruteCN¥88.96b
Autres dépensesCN¥55.41b
Les revenusCN¥33.55b

Derniers bénéfices déclarés

Sep 30, 2022

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)1.19
Marge brute11.54%
Marge bénéficiaire nette4.35%
Ratio dettes/capitaux propres30.8%

Quelles ont été les performances à long terme de LFCH.Y?

Voir les performances historiques et les comparaisons

Dividendes

7.1%
Rendement actuel des dividendes
55%
Ratio de distribution

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2022/11/12 18:32
Cours de l'action en fin de journée2022/11/10 00:00
Les revenus2022/09/30
Revenus annuels2021/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

China Life Insurance Company Limited est couverte par 37 analystes. 22 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Mark William KellockBarclays
Tianjiao YuBernstein
Michael LiBofA Global Research